BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 21215315)

  • 1. N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity.
    De Petrocellis L; Guida F; Moriello AS; De Chiaro M; Piscitelli F; de Novellis V; Maione S; Di Marzo V
    Pharmacol Res; 2011 Apr; 63(4):294-9. PubMed ID: 21215315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature.
    Luongo L; Costa B; D'Agostino B; Guida F; Comelli F; Gatta L; Matteis M; Sullo N; De Petrocellis L; de Novellis V; Maione S; Di Marzo V
    Pharmacol Res; 2012 Sep; 66(3):243-50. PubMed ID: 22634607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat.
    Alsalem M; Millns P; Altarifi A; El-Salem K; Chapman V; Kendall DA
    BMC Pharmacol Toxicol; 2016 Jul; 17(1):31. PubMed ID: 27439609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
    Ursu D; Knopp K; Beattie RE; Liu B; Sher E
    Eur J Pharmacol; 2010 Sep; 641(2-3):114-22. PubMed ID: 20576527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential.
    Appendino G; De Petrocellis L; Trevisani M; Minassi A; Daddario N; Moriello AS; Gazzieri D; Ligresti A; Campi B; Fontana G; Pinna C; Geppetti P; Di Marzo V
    J Pharmacol Exp Ther; 2005 Feb; 312(2):561-70. PubMed ID: 15356216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
    Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
    Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.
    Szymaszkiewicz A; Włodarczyk J; Wasilewski A; Di Marzo V; Storr M; Fichna J; Zielińska M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1357-1364. PubMed ID: 32002574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
    Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of olvanil and anandamide on vagal C-fiber subtypes in guinea pig lung.
    Lee MG; Weinreich D; Undem BJ
    Br J Pharmacol; 2005 Oct; 146(4):596-603. PubMed ID: 16056239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell death.
    Lam PM; Hainsworth AH; Smith GD; Owen DE; Davies J; Lambert DG
    J Neurochem; 2007 Aug; 102(3):801-11. PubMed ID: 17442052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
    Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V
    Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
    Tsumura M; Sobhan U; Muramatsu T; Sato M; Ichikawa H; Sahara Y; Tazaki M; Shibukawa Y
    Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats.
    Fischbach T; Greffrath W; Nawrath H; Treede RD
    J Neurophysiol; 2007 Aug; 98(2):929-38. PubMed ID: 17581853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels.
    De Petrocellis L; Chu CJ; Moriello AS; Kellner JC; Walker JM; Di Marzo V
    Br J Pharmacol; 2004 Sep; 143(2):251-6. PubMed ID: 15289293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
    Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N
    Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
    Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
    Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels.
    McArthur JR; Finol-Urdaneta RK; Adams DJ
    Br J Pharmacol; 2019 Jul; 176(13):2264-2278. PubMed ID: 30927254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The investigation of allosteric regulation mechanism of analgesic effect using SD rat taste bud tissue biosensor.
    Xiao S; Zhang Y; Song P; Xie J; Pang G
    Biosens Bioelectron; 2019 Feb; 126():815-823. PubMed ID: 30602263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.